These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10417445)

  • 21. Comparative study of nail sampling techniques in onychomycosis.
    Shemer A; Davidovici B; Grunwald MH; Trau H; Amichai B
    J Dermatol; 2009 Jul; 36(7):410-4. PubMed ID: 19583689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients.
    Gupta AK; Jain HC; Lynde CW; Macdonald P; Cooper EA; Summerbell RC
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):244-8. PubMed ID: 10906646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology and management of onychomycosis in private dermatological practice in France].
    Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M
    Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of antifungal therapy, part II: treatment rationale, including specific patient populations.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(3):168-75. PubMed ID: 18569273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superficial white onychomycosis revisited.
    Baran R; Hay R; Perrin C
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):569-71. PubMed ID: 15324395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common variable immunodeficiency in systemic lupus erythematosus.
    Fernández-Castro M; Mellor-Pita S; Citores MJ; Muñoz P; Tutor-Ureta P; Silva L; Vargas JA; Yebra-Bango M; Andreu JL
    Semin Arthritis Rheum; 2007 Feb; 36(4):238-45. PubMed ID: 17276173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and mycology of onychomycosis in autoimmune patients.
    Boonchai W; Kulthanan K; Maungprasat C; Suthipinittham P
    J Med Assoc Thai; 2003 Nov; 86(11):995-1000. PubMed ID: 14696780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma.
    Cuétara MS; Alhambra A; Moreno JM; Postigo C; Moragues MD; Pontón J; del Palacio A
    Br J Dermatol; 2006 Jun; 154(6):1200-2. PubMed ID: 16704657
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis.
    Sumikawa M; Egawa T; Honda I; Yamamoto Y; Sumikawa Y; Kubota M
    J Dermatol; 2007 Jul; 34(7):456-64. PubMed ID: 17584323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Proximal white subungual onychomycosis due to fusarium species].
    Mallo-García S; Coto-Segura P; Santos-Juanes-Jiménez J
    Actas Dermosifiliogr; 2008 Nov; 99(9):742-3. PubMed ID: 19087820
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcome of renal transplantation in patients with systemic lupus erythematosus.
    Deegens JK; Artz MA; Hoitsma AJ; Wetzels JF
    Transpl Int; 2003 Jun; 16(6):411-8. PubMed ID: 12819872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties.
    Richert B; André J; Bourguignon R; de la Brassinne M
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):728-30. PubMed ID: 15482310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
    Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients.
    Piraccini BM; Tosti A
    Arch Dermatol; 2004 Jun; 140(6):696-701. PubMed ID: 15210460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dystrophic onychomycosis due to Microsporum gypseum.
    Romano C; Ghilardi A; Fimiani M
    Mycoses; 2006 Jul; 49(4):335-7. PubMed ID: 16784450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal white subungual onychomycosis in a kidney transplant patient.
    Chang P; Arenas R
    Int J Dermatol; 1995 Aug; 34(8):591. PubMed ID: 7591448
    [No Abstract]   [Full Text] [Related]  

  • 40. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.